Long-term results with custom-linked iodine-125 seeds and real-time brachytherapy in low- and intermediate-risk prostate cancer.

J Contemp Brachytherapy · 2022 · PMC9528840 · PMID 36199987

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

All these indicate that long-term results worsen when using only EBRT with or without hormonal therapy; therefore, maintaining 88% control at 10 years in the intermediate-risk group of our study was highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.